カルシウム炭酸ポリモルフは,血小板濃度とカルシウム放出を通じて,シトラ酸血の凝固を促進します
Roni M Hendler1,2, Orly E Weiss1,3, Bhuwan Bhaskar1
1Department of Molecular Biology, Ariel University, Ariel, Israel.
Journal of applied biomaterials & functional materials
|February 19, 2026
まとめ
カルシウム炭酸 (CaCO3) は,チラート抗凝固による出血の治療に有望であることが示されています. この研究では,CaCO3が血の凝固と血小板の集約を効果的に促進し,シトラートの作用を相殺することを発見しました.
科学分野:
- バイオケミストリー バイオケミストリー
- 血液学 ヘマトロジ
- 材料科学 材料科学とは
背景:
- 輸血および体外療法で使用されるチラート抗凝固剤は,イオン化されたカルシウムをケラートし,低カルシウムと凝固不全を引き起こす.
- このシトラート誘発の凝固症は出血のリスクを高め,出血ショックを引き起こす可能性があります.
- この文脈での出血のための現在の局所的血静止剤は,物理的障壁として作用するか,凝固経路を活性化します.
研究 の 目的:
- カルシウム炭酸 (CaCO3) を,チラート誘発凝固病に対する潜在的血液静止剤として調査する.
- カルシウムイオンの放出と血小板の集積を通じて凝結を促進するCaCO3の能力を評価する.
主な方法:
- 様々なCaCO3ポリモルフ (アラゴニット,カルシット) で処理されたシトラ酸血を用いたインビトロ試験.
- 凝固時間 (プロトロンビン時間,部分血栓形成時間) の測定.
- 自由カルシウムレベルと血小板数/結合の評価.
主要な成果:
- CaCO3ポリモルファは,シテート血液の凝固を著しく強化しました.
- カルシート粒子は凝固時間を最大2倍まで短縮し,プロトロンビン時間を13%,部分血小板形成時間を24%短縮しました.
- カルシートは血のフリーカルシウムを2.6倍増加させ,循環する血小板を13%減少させ,直接結合する血小板を減少させた.
結論:
- CaCO3は,特にカルサイトは,シトラート誘発凝固症の静止剤としての潜在能力を示しています.
- カルシウムを上昇させ,血小板を集約するという二重作用は,輸血医学と重症治療における出血の管理に新しいアプローチを提供します.
関連する概念動画
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation
11.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Factors Affecting Solubility
37.5K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Chȃtelier’s principle. Consider the dissolution of silver iodide:
37.5K
Formation of the Platelet Plug
9.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.8K
Clot Retraction and Fibrinolysis
9.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.5K


